213 related articles for article (PubMed ID: 19917957)
21. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
Almeida S; Maillard C; Itin P; Hohl D; Huber M
J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586
[TBL] [Abstract][Full Text] [Related]
22. Inherited cylindromas: lessons from a rare tumour.
Rajan N; Ashworth A
Lancet Oncol; 2015 Sep; 16(9):e460-e469. PubMed ID: 26370355
[TBL] [Abstract][Full Text] [Related]
23. A case of Brooke-Spiegler syndrome with a new mutation in the CYLD gene.
Heinritz W; Grunewald S; Strenge S; Schütz A; Froster UG; Glander HJ; Paasch U; Simon JC
Br J Dermatol; 2006 May; 154(5):992-4. PubMed ID: 16634909
[No Abstract] [Full Text] [Related]
24. A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin's lymphoma.
Hunstig F; Schulz S; Nieten I; Froster U; Boltze C; Schliemann S; Hochhaus A; La Rosée P
J Cancer Res Clin Oncol; 2016 Apr; 142(4):845-8. PubMed ID: 26660106
[TBL] [Abstract][Full Text] [Related]
25. Report of Three Novel Germline CYLD Mutations in Unrelated Patients with Brooke-Spiegler Syndrome, Including Classic Phenotype, Multiple Familial Trichoepitheliomas and Malignant Transformation.
Tantcheva-Poór I; Vanecek T; Lurati MC; Rychly B; Kempf W; Michal M; Kazakov DV
Dermatology; 2016; 232(1):30-7. PubMed ID: 26329847
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells.
Rajan N; Andersson MK; Sinclair N; Fehr A; Hodgson K; Lord CJ; Kazakov DV; Vanecek T; Ashworth A; Stenman G
J Pathol; 2016 Jun; 239(2):197-205. PubMed ID: 26969893
[TBL] [Abstract][Full Text] [Related]
27. A case of Brooke-Spiegler syndrome with a novel germline deep intronic mutation in the CYLD gene leading to intronic exonization, diverse somatic mutations, and unusual histology.
Kazakov DV; Thoma-Uszynski S; Vanecek T; Kacerovska D; Grossmann P; Michal M
Am J Dermatopathol; 2009 Oct; 31(7):664-73. PubMed ID: 19668078
[TBL] [Abstract][Full Text] [Related]
28. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.
Blake PW; Toro JR
Hum Mutat; 2009 Jul; 30(7):1025-36. PubMed ID: 19462465
[TBL] [Abstract][Full Text] [Related]
29. Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor.
Ponti G; Ruini C; Girolomoni G; Pellacani G; Farnetani F; Pastorino L; Ghiorzo P; Witkowski AM; Bianchi-Scarrà G; Tomasi A; Loschi P; Nasti S
Future Oncol; 2014 Feb; 10(3):345-50. PubMed ID: 24559443
[TBL] [Abstract][Full Text] [Related]
30. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene.
Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M
Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090
[TBL] [Abstract][Full Text] [Related]
31. A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family.
Zhu R; Xu J; Shen J; Li W; Tan F; Li C; Wei Z; Liu Y; Bai Y
Mol Genet Genomic Med; 2020 Oct; 8(10):e1441. PubMed ID: 32783365
[TBL] [Abstract][Full Text] [Related]
32. A novel frameshift mutation in the cylindromatosis (CYLD) gene in a Chinese family with multiple familial trichoepithelioma.
Wu JW; Xiao SX; Huo J; An JG; Ren JW
Arch Dermatol Res; 2014 Nov; 306(9):857-60. PubMed ID: 25234269
[TBL] [Abstract][Full Text] [Related]
33. Familial cylindromatosis and brooke-spiegler syndrome: a review of current therapeutic approaches and the surgical challenges posed by two affected families.
Rajan N; Trainer AH; Burn J; Langtry JA
Dermatol Surg; 2009 May; 35(5):845-52. PubMed ID: 19397670
[No Abstract] [Full Text] [Related]
34. The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene.
Farkas K; Deák BK; Sánchez LC; Martínez AM; Corell JJ; Botella AM; Benito GM; López RR; Vanecek T; Kazakov DV; Kromosoeto JN; van den Ouweland AM; Varga J; Széll M; Nagy N
BMC Genet; 2016 Feb; 17():36. PubMed ID: 26861065
[TBL] [Abstract][Full Text] [Related]
35. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages.
Poblete Gutiérrez P; Eggermann T; Höller D; Jugert FK; Beermann T; Grussendorf-Conen EI; Zerres K; Merk HF; Frank J
J Invest Dermatol; 2002 Aug; 119(2):527-31. PubMed ID: 12190880
[TBL] [Abstract][Full Text] [Related]
36. Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.
Danilenko M; Stamp E; Stocken DD; Husain A; Zangarini M; Cranston A; Stones R; Sinclair N; Hodgson K; Bowett SA; Roblin D; Traversa S; Plummer R; Veal G; Langtry JAA; Ashworth A; Burn J; Rajan N
JAMA Dermatol; 2018 Aug; 154(8):913-921. PubMed ID: 29955768
[TBL] [Abstract][Full Text] [Related]
37. Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors.
Kazakov DV; Schaller J; Vanecek T; Kacerovska D; Michal M
J Cutan Pathol; 2010 Aug; 37(8):886-90. PubMed ID: 20132422
[TBL] [Abstract][Full Text] [Related]
38. Tracking tumor kinetics in patients with germline CYLD mutations.
Brown S; Worthy SA; Langtry JAA; Rajan N
J Am Acad Dermatol; 2018 Nov; 79(5):949-951. PubMed ID: 29660420
[No Abstract] [Full Text] [Related]
39. Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndrome.
Andersson MK; Kölby L; Nilsson JA; Stenman G
J Plast Surg Hand Surg; 2019 Apr; 53(2):71-75. PubMed ID: 30676842
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
